We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Review · February 10, 2021

Significance of the Genomic Landscape of a De Novo Endocrine-Resistant Metastatic HR+ Breast Cancer

Breast Cancer: Basic and Clinical Research

 

Additional Info

Breast Cancer: Basic and Clinical Research
Significance of the Genomic Landscape of a De Novo Endocrine-Resistant Metastatic Hormone Receptor–Positive Breast Cancer
Breast Cancer (Auckl) 2020 Feb 01;14(xx)1178223420976387, M Sarma, Y Abdou, A Dhakal, S Gandhi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading